L'Effetto di un Nuovo Ortese di Distrazione Articolare del Ginocchio per il Trattamento dell'Osteoartrite Mediale del Ginocchio
L'Effetto di un Nuovo Tutore di Distrazione Articolare del Ginocchio per il Trattamento dell'Osteoartrite del Ginocchio Mediale
The Effect of a Novel Joint Distraction Knee Orthosis for Treating Medial Knee Osteoarthritis
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Benjamin M Koerber, PhD
- Numero di telefono: 8147909364
- Email: benk@icarusmedical.com
Backup dei contatti dello studio
- Nome: Evan Eckersley
- Numero di telefono: (570) 955-9662
- Email: evan@icarusmedical.com
Luoghi di studio
-
-
Virginia
-
Charlottesville, Virginia, Stati Uniti, 22902
- Icarus Medical Innovations
-
Contatto:
- Ben Koerber
- Numero di telefono: 8147909364
- Email: koerberbm1@gmail.com
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Adults aged 30-70, as significant knee OA is very common for people under 30, and would be more likely correlated to trauma.
- Able to ambulate with or without assistive devices
- Body-mass index (BMI) under 35. This is to minimize the effect of the variable of how the brace fits on the patient. The finding of pain relief will extrapolate to any BMI.
- Willingness and ability to comply with scheduled visits and study procedures
- Willingness and ability to fill out patient questionnaires written in English
- Ability to provide informed consent
- Clinical diagnosis of medial or lateral compartment knee osteoarthritis requiring a KO.
- Subject is suitable for unilateral bracing
Exclusion Criteria:
- Significant cognitive impairment interfering with study assessments
- Active infections or wounds at the foot or leg
- Severe spasticity that limits brace fitting or functioning
- History of severe lower limb deformities that would preclude brace use
- History of major joint surgery or joint implants, such as total knee replacement
- Other neurological or musculoskeletal conditions unrelated to the lower limbs that significantly impact gait
- Non-ambulatory
- Inability to travel for study procedures or fill out required surveys
- Medical conditions of interest
- Pregnant women
- Prisoners
- Clinical diagnosis of knee osteoarthritis that is not specific to the knee's medial or lateral compartment (multicompartmental, or patellofemoral knee osteoarthritis)
- Self-reported pain score of less than 3 out of 10 in the medial compartment.
- Varus or valgus deformity greater than 12°
- Inability to read/write/communicate in English
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: The Effect of a Novel Joint Distraction Knee Orthosis for Treating Medial Knee Osteoarthritis
Patients experiencing unicompartment (medial or lateral) osteoarthritis will receive Icarus Adonis Joint Distraction brace. Patients will wear the brace for 12 weeks and document how often they wear the brace and their pain scores. Patients will fill out outcome surveys at 2, 4, 6, 8, and 12 weeks. |
Patients will receive Icarus Adonis Joint Distraction brace. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Lasso di tempo: Baseline, 2, 4, 8, 12 weeks
|
Scored 0 to 100, where 0 represents total knee disability and 100 represents perfect knee |
Baseline, 2, 4, 8, 12 weeks
|
|
European Quality of Life-5 Dimensions (EQ-5D-5L)
Lasso di tempo: Baseline, 2, 4, 8, 12 weeks.
|
0 to 1, where 1 is perfect health |
Baseline, 2, 4, 8, 12 weeks.
|
|
Visual Analogue Scale (VAS)
Lasso di tempo: Baseline, 2, 4, 8, 12 weeks.
|
0-100, zero meaning no pain, 10 meaning severe pain |
Baseline, 2, 4, 8, 12 weeks.
|
|
Functional Mobility Assessments
Lasso di tempo: Baseline, 2, 4, 8, 12 weeks
|
6 minute walk test |
Baseline, 2, 4, 8, 12 weeks
|
|
Functional Mobility Assessment
Lasso di tempo: Baseline, 2, 4, 8, 12 weeks
|
5 times Sit to Stand test |
Baseline, 2, 4, 8, 12 weeks
|
|
Functional Mobility Assessment
Lasso di tempo: Baseline, 2, 4, 8, 12 weeks
|
Timed Up and Go test |
Baseline, 2, 4, 8, 12 weeks
|
Collaboratori e investigatori
Sponsor
Sponsor
Pubblicazioni e link utili
Pubblicazioni generali
- Roos EM, Lohmander LS. The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes. 2003 Nov 3;1:64. doi: 10.1186/1477-7525-1-64.
- Boonstra AM, Schiphorst Preuper HR, Reneman MF, Posthumus JB, Stewart RE. Reliability and validity of the visual analogue scale for disability in patients with chronic musculoskeletal pain. Int J Rehabil Res. 2008 Jun;31(2):165-9. doi: 10.1097/MRR.0b013e3282fc0f93.
- Losina E, Paltiel AD, Weinstein AM, Yelin E, Hunter DJ, Chen SP, Klara K, Suter LG, Solomon DH, Burbine SA, Walensky RP, Katz JN. Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty. Arthritis Care Res (Hoboken). 2015 Feb;67(2):203-15. doi: 10.1002/acr.22412.
- Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014 Jul 18;5(3):351-61. doi: 10.5312/wjo.v5.i3.351. eCollection 2014 Jul 18.
- Cherian JJ, Bhave A, Kapadia BH, Starr R, McElroy MJ, Mont MA. Strength and Functional Improvement Using Pneumatic Brace with Extension Assist for End-Stage Knee Osteoarthritis: A Prospective, Randomized trial. J Arthroplasty. 2015 May;30(5):747-53. doi: 10.1016/j.arth.2014.11.036. Epub 2014 Nov 29.
- Parween R, Shriram D, Mohan RE, Lee YHD, Subburaj K. Methods for evaluating effects of unloader knee braces on joint health: a review. Biomed Eng Lett. 2019 Jan 23;9(2):153-168. doi: 10.1007/s13534-019-00094-z. eCollection 2019 May.
- Heinemann AW, Bode RK, O'Reilly C. Development and measurement properties of the Orthotics and Prosthetics Users' Survey (OPUS): a comprehensive set of clinical outcome instruments. Prosthet Orthot Int. 2003 Dec;27(3):191-206. doi: 10.1080/03093640308726682.
- Long H, Liu Q, Yin H, Wang K, Diao N, Zhang Y, Lin J, Guo A. Prevalence Trends of Site-Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 2019. Arthritis Rheumatol. 2022 Jul;74(7):1172-1183. doi: 10.1002/art.42089. Epub 2022 Jun 2.
- Devlin N, Roudijk B, Ludwig K, editors. Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide [Internet]. Cham (CH): Springer; 2022. No abstract available. Available from http://www.ncbi.nlm.nih.gov/books/NBK589304/
- Jm B, Pw S, Sa L. Lower Extremity Functional Scale (LEFS).
- Nori SL, Stretanski MF. Foot Drop. In: StatPearls. StatPearls Publishing; 2024. Accessed September 24, 2024. http://www.ncbi.nlm.nih.gov/books/NBK554393/
- Ciolino JD, Kaizer AM, Bonner LB. Guidance on interim analysis methods in clinical trials. J Clin Transl Sci. 2023 May 15;7(1):e124. doi: 10.1017/cts.2023.552. eCollection 2023.
- Stetter BJ, Fiedler J, Arndt M, Stein T, Sell S. Impact of a Semi-Rigid Knee Orthotic Intervention on Pain, Physical Activity, and Functional Capacity in Patients with Medial Knee Osteoarthritis. J Clin Med. 2024 Mar 7;13(6):1535. doi: 10.3390/jcm13061535.
- Wilder FV, Barrett JP Jr. The association between medication usage and dropout status among participants of an exercise study for people with osteoarthritis. Phys Ther. 2005 Feb;85(2):142-9.
- Balkman GS, Bamer AM, Stevens PM, Weber EL, Morgan SJ, Salem R, Amtmann D, Hafner BJ. Development and initial validation of the Orthotic Patient-Reported Outcomes-Mobility (OPRO-M): An item bank for evaluating mobility of people who use lower-limb orthoses. PLoS One. 2023 Nov 2;18(11):e0293848. doi: 10.1371/journal.pone.0293848. eCollection 2023.
- Paluska SA, McKeag DB. Knee braces: current evidence and clinical recommendations for their use. Am Fam Physician. 2000 Jan 15;61(2):411-8, 423-4.
- DeRogatis M, Anis HK, Sodhi N, Ehiorobo JO, Chughtai M, Bhave A, Mont MA. Non-operative treatment options for knee osteoarthritis. Ann Transl Med. 2019 Oct;7(Suppl 7):S245. doi: 10.21037/atm.2019.06.68.
- McCormack DJ, Puttock D, Godsiff SP. Medial compartment osteoarthritis of the knee: a review of surgical options. EFORT Open Rev. 2021 Feb 1;6(2):113-117. doi: 10.1302/2058-5241.6.200102. eCollection 2021 Feb.
- Perdisa F, Bordini B, Salerno M, Traina F, Zaffagnini S, Filardo G. Total Knee Arthroplasty (TKA): When Do the Risks of TKA Overcome the Benefits? Double Risk of Failure in Patients up to 65 Years Old. Cartilage. 2023 Sep;14(3):305-311. doi: 10.1177/19476035231164733. Epub 2023 Apr 19.
- Franklin PD, Suleiman L, Ibrahim SA. Racial/Ethnic and Sex Differences in Total Knee Arthroplasty Outcomes. JAMA Netw Open. 2020 May 1;3(5):e205000. doi: 10.1001/jamanetworkopen.2020.5000. No abstract available.
- Wang MC, Chan PH, Paxton EW, Bellows J, Koplan K, Rabrenovich V, Convissar J, Reddy NC, Grimsrud CD, Navarro RA. Factors Influencing Patient Satisfaction With Care and Surgical Outcomes for Total Hip and Knee Replacement. Perm J. 2021 Nov 3;25:21.043. doi: 10.7812/TPP/21.043.
- Goodman SM, Mehta B, Zhang M, Szymonifka J, Nguyen JT, Lee L, Figgie MP, Parks ML, Dey SA, Crego D, Russell LA, Mandl LA, Bass AR. Disparities in Total Hip Arthroplasty Outcomes: Census Tract Data Show Interactions Between Race and Community Deprivation. J Am Acad Orthop Surg. 2018 Nov 1;26(21):e457-e464. doi: 10.5435/JAAOS-D-17-00393.
- Chun DS, Leonard AK, Enchill Z, Suleiman LI. Racial Disparities in Total Joint Arthroplasty. Curr Rev Musculoskelet Med. 2021 Dec;14(6):434-440. doi: 10.1007/s12178-021-09718-3. Epub 2021 Oct 9.
- Ezomo OT, Sun D, Gronbeck C, Harrington MA, Halawi MJ. Where Do We Stand Today on Racial and Ethnic Health Disparities? An Analysis of Primary Total Hip Arthroplasty From a 2011-2017 National Database. Arthroplast Today. 2020 Nov 2;6(4):872-876. doi: 10.1016/j.artd.2020.10.002. eCollection 2020 Dec.
- Segal NA. Bracing and orthoses: a review of efficacy and mechanical effects for tibiofemoral osteoarthritis. PM R. 2012 May;4(5 Suppl):S89-96. doi: 10.1016/j.pmrj.2012.01.018.
- Alam M, Choudhury IA, Bin Mamat A. Mechanism and design analysis of articulated ankle foot orthoses for drop-foot. ScientificWorldJournal. 2014;2014:867869. doi: 10.1155/2014/867869. Epub 2014 Apr 30.
- Kobayashi E, Hiratsuka K, Haruna H, Kojima N, Himuro N. Efficacy of Knee-Ankle-Foot Orthosis on Functional Mobility and Activities of Daily Living in Patients with Stroke: A Systematic Review of Case Reports. J Rehabil Med. 2022 Jul 7;54:jrm00290. doi: 10.2340/jrm.v54.87.
- Bashir AZ, Dinkel DM, Pipinos II, Johanning JM, Myers SA. Patient Compliance With Wearing Lower Limb Assistive Devices: A Scoping Review. J Manipulative Physiol Ther. 2022 Feb;45(2):114-126. doi: 10.1016/j.jmpt.2022.04.003. Epub 2022 Jun 24.
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- 303260
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
IPD must be deidentified according to UVA IRB standard. If this would be the case then we would plan to share IPD and publish this study.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .